April 26, 2019

April 26, 2019

American Cancer Society seeks more drivers to take patients to appointments

Click Orlando – April 26

For instance, Grossi drives from Orlando to the Moffitt Cancer Center frequently. She has a couple of patients that she’s been driving for several years back and forth, Coover said.


Treatment Toxicities: Present, but Manageable

Healio – April 2019

In this installment of In Practice, Frederick L. Locke, MD, Co-Leader of the Immunology Program and Director of the Immune Cell Therapy Program at Moffitt Cancer Center, discusses the side effects and toxicities of CAR T-cell treatments.


RING THE BELL: Brave veteran mom battles cancer while pregnant, final chemo day

WFLA – April 25

Monday marked a major milestone for Jessica. It was her final chemotherapy treatment at Moffitt Cancer Center in in Tampa after fighting a non-stop, grueling battle.


Moffitt Researchers Find BRAF Protein Modification Could Slow Tumor Growth

R&D – April 24

Researchers in Moffitt Cancer Center's Donald A. Adam Melanoma and Skin Cancer Center of Excellence have discovered a signaling pathway between cytokines and BRAF that promotes tumor growth.


BRAF protein modification could slow tumour growth

eCancer – April 25

Researchers in Moffitt Cancer Center's Donald A. Adam Melanoma and Skin Cancer Center of Excellence have discovered a signalling pathway between cytokines and BRAF that promotes tumour growth.


InformedDNA Increases Genetic Testing’s Affordability, Accessibility

Tampa Bay Inno – April 24

Co-founder and chief medical officer Dr. Rebecca Sutphen used to manage the genetic programs at both the Moffitt Cancer Center and Johns Hopkins All Children’s Hospital. During that time, Dr. Sutphen noticed a lack of access to genetics experts in local community settings, outside of large academic centers.


Sunscreen dispenser in Boca park, a first for Run from the Rays founder

The Boca Voice – April 23

A longtime advocate for skin cancer research, particularly for melanoma, Nachlas’ race proceeds last year went to Melanoma Research at the Moffitt Center and the Richard David Kann Melanoma Foundation. Several local nonprofits with screening programs and treatment also received benefits.


Dr. Shah on Ongoing Trials in MCL

OncLive – April 22

Bijal D. Shah, MD, oncologist/hematologist, Moffitt Cancer Center, discusses ongoing trials in the field of mantle cell lymphoma (MCL).


Special Assessments Are Needed When Treating Older Adults With Cancer

Medical Health News – April 22

CRASH and other oncology assessment tools for seniors can be found at the Moffit Cancer Center website.


Dr. Shah on Challenges With Developing MCL Clinical Trials

OncLive – April 19

Bijal D. Shah, MD, associate member, Department of Malignant Hematology, Moffitt Cancer Center, assistant professor of oncology, University of South Florida, discusses challenges with conducting clinical trials in mantle cell lymphoma (MCL).


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.